DOPPELHERZ
Live / Registered — Registered — Section 71 accepted (as of 05 Feb 2026)
What this means for you
Registered since 26 Mar 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Mar 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79237116
- Registration number
- 5706248
- Mark type
- Word mark
- Filed
- 11 Jun 2018
- Published for opposition
- 08 Jan 2019
- Registered
- 26 Mar 2019
- Next maintenance filing
- §71 ten-year affidavit of use, due by 26 Mar 2029 (grace period to 26 Sept 2029)
- Attorney of record
- David P. Goldberg
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and dietary products for medical purposes, namely the cardiovascular system, the digestive system, the reproductive system, the genitourinary system and the musculoskeletal system; food supplements
Owner
- Queisser Pharma GmbH & Co. KG, Flensburg, DE
- Queisser Pharma GmbH & Co. KG, DE
- Queisser Pharma GmbH & Co. KG, DE
Prosecution history
- 05 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 05 Feb 2026 — REGISTERED-SEC.71 ACCEPTED
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Sept 2025 — TEAS SECTION 71 RECEIVED
- 24 Sept 2020 — INTERNATIONAL REGISTRATION RENEWED
- 16 Aug 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Jul 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 29 Jul 2019 — FINAL DISPOSITION PROCESSED
- 26 Jun 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
- 08 Jan 2019 — PUBLISHED FOR OPPOSITION
- 19 Dec 2018 — NOTICE OF PUBLICATION
- 14 Nov 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE